Thomsen Pharma ApS: Financial statements 2020
CVR: 40620060
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Thomsen Pharma ApS (CVR 40620060) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -28,750 and a net result of DKK 1,471,168. Equity in the 2020 report amounted to DKK 4,690,829. The solvency ratio was 99.3%.
- Gross Profit
- DKK -28,750
- Profit/Loss
- DKK 1,471,168
- Equity
- DKK 4,690,829
- Total Assets
- DKK 4,721,679
Official annual report
How creditworthy is Thomsen Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Thomsen Pharma ApS has published its interim report for the period April 2, 2019 to December 31, 2019.
About Thomsen Pharma ApS
Thomsen Pharma ApS is a Danish company of the type Anpartsselskab based in Glamsbjerg, founded in 2019. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Mikael Søndergaard Thomsen. The company is owned by Mikael Søndergaard Thomsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,978 and a net result of DKK -16,315 compared with DKK -4,005,382 the year before. Equity in the 2025 report amounted to DKK 607,713.